Kallikrein-mediated activation of PARs in inflammation and nociception

Inflammation Research

Volumn 56, Issue 3, 2007, Pages S499-S502

  Oikonomopoulou, Katerina ^a   Hansen, Kristina K ^b   Chapman, Kevin ^b   Vergnolle, Nathalie ^b   Diamandis, Eleftherios P ^a   Hollenberg, Morley D ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; KALLIKREIN 14; KALLIKREIN 5; KALLIKREIN 6; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CELL SURFACE; CONTROLLED STUDY; EDEMA; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MECHANICAL NOCICEPTION; MOUSE; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; THERMAL NOCICEPTION; THROMBOCYTE AGGREGATION; VASODILATATION;

EID: 67349187245     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/BF03353889     Document Type: Article

References (12)

1. Steinhoff, M., Buddenkotte, J., Shpacovitch, V., et al. Proteinase-activated receptors: transducers of proteinasemediated signaling in inflammation and immune response. Endocr Rev. 2005; 26:1–43.
2. Hollenberg MD, Compton SJ. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev. 2002 Jun; 54(2): 203–17.
3. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004 Apr; 84(2): 579–621.
4. Oikonomopoulou K, Hansen KK, Saifeddine M., et al. Proteinase-mediated cell signalling: targeting proteinaseactivated receptors (PARs) by kallikreins and more. Biol Chem. 2006 Jun; 387(6): 677–85.
5. Vergnolle, N., Wallace, J.L., Bunnett, N.W., and Hollenberg, M.D. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci. (2001) 22: 146–52.
6. Noorbakhsh, F., Vergnolle, N., Hollenberg, M.D., and Power, C. Proteinase-activated receptors in the nervous system. Nat Rev Neurosci. 2003; 4: 981–90.
7. Borgono, C.A., and Diamandis, E.P. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer. 2004; 4: 876–90.
8. Oikonomopoulou K, Hansen KK, Saifeddine M., et al. Kallikrein-mediated cell signalling: targeting proteinasesactivated receptors (PARs). Biol Chem. 2006; 387: 817–24.
9. Oikonomopoulou K, Hansen KK, Saifeddine M., et al. Proteinase-activated receptors (PARs): targets for kallikrein signalling. J Biol Chem. 2006; 281: 32095–112.
10. Kamath, L., Mydam A., Foss, F., Kuliopulos, A. Aignaling fromprotease-activa ted receptor-1 inhibits migration and invarion of breast cancer cell. Cncer res. 2001; 61: 5933–40.
11. Compton SJ, Sandhu S, Wijesuriya SJ, Hollenberg MD. Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling. Biochem J. 2002 Dec 1; 368(Pt 2): 495–505.
12. Compton SJ, McGuire JJ, Saifeddine M, Hollenberg MDRestricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aorta. Can J Physiol Pharmacol. 2002 Oct; 80(10): 987–92.